No Data
No Data
No Data
No Data
No Data
Express News | Tango Therapeutics Shares Are Trading Higher After Cantor Fitzgerald Initiated Coverage on the Stock With an Overweight Rating
Moomoo 24/7Apr 4 07:55 ET
Express News | Cantor Fitzgerald Initiates Coverage On Tango Therapeutics With Overweight Rating
Moomoo 24/7Apr 4 07:02 ET
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version BOSTON--(BUSINESS WIRE)--Apr. 1, 2024-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of
Tango TherapeuticsApr 1 00:00 ET
Earnings Update: Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported And Analysts Are Boosting Their Estimates
Tango Therapeutics, Inc. (NASDAQ:TNGX) shareholders are probably feeling a little disappointed, since its shares fell 7.8% to US$8.50 in the week after its latest yearly results. Despite revenue
Simply Wall StMar 21 06:43 ET
Buy Rating Affirmed for Tango Therapeutics on Strong Pipeline and Financial Stability
TipRanksMar 21 02:17 ET
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 20 07:06 ET
No Data
No Data